Merav Yogev‐Falach

Medicine · Health Sciences

10h-index867citations14works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(9), Cholinesterase and Neurodegenerative Diseases(7), Computational Drug Discovery Methods(4), Parkinson's Disease Mechanisms and Treatments(2), Nanoplatforms for cancer theranostics(2)

Publications13 total

Corrigendum to “Molecular imaging of neurodegeneration by a novel cross-disease biomarker” [Exp. Neurol. 219/1 (2009) 274–283]
Experimental Neurology·2011
Errata: Novel fluorescence molecular imaging of chemotherapy-induced intestinal apoptosis
Journal of Biomedical Optics·2011Open Access
Molecular imaging of neurodegeneration by a novel cross-disease biomarker
Experimental Neurology·2009· 15 cited
Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis
APOPTOSIS·2009· 46 cited
Novel fluorescence molecular imaging of chemotherapy-induced intestinal apoptosis
Journal of Biomedical Optics·2009· 10 cited
Multifunctional Neuroprotective Derivatives of Rasagiline as Anti-Alzheimer's Disease Drugs
Neurotherapeutics·2008· 108 citedOpen Access
A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo‐APP translation and processing
The FASEB Journal·2006· 85 cited
Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition
Journal of Neuroscience Research·2004· 163 cited
PKC and MAP kinase-dependent processing of amyloid precursor protein (APP) by neuroprotective propargylamine cholinesterase inhibitors derived from rasagiline and nonsteroidal anti-inflammatory drugs
2004· 1 cited
Regulation of protein kinase C by the anti‐Parkinson drug, MAO‐B inhibitor, rasagiline and its derivatives, <i>in vivo</i>
Journal of Neurochemistry·2004· 108 cited
The importance of propargylamine moiety in the anti‐ Parkinson drug rasagiline and its derivatives for MAPK‐ dependent amyloid precursor protein processing
The FASEB Journal·2003· 117 cited
Amyloid Processing and Signal Transduction Properties of Antiparkinson‐Antialzheimer Neuroprotective Drugs Rasagiline and TV3326
Annals of the New York Academy of Sciences·2003· 26 cited
The involvement of mitogen‐activated protein (MAP) kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline
The FASEB Journal·2002· 103 cited

Frequent Co-authors

Moussa B. H. Youdim(9), Tamar Amit(9), Orit Bar‐Am(8), Anat Shirvan(5), Ayelet Reshef(5), Ilan Ziv(5), Orly Weinreb(4), Marta Weinstock(3), Hagit Grimberg(3), Galit Levin(3), Avi Cohen(2), Orit Bar(1), Wakako Maruyama(1), M Naoi(1), Yotam Sagi(1), Silvia Mandel(1), Yael Avramovich‐Tirosh(1), Yael Avramovich(1), Avi J. Cohen(1)